PMID- 28099880 OWN - NLM STAT- MEDLINE DCOM- 20170329 LR - 20200106 IS - 1873-474X (Electronic) IS - 0736-5748 (Linking) VI - 57 DP - 2017 Apr TI - Modifications of inhibitory transmission onto pyramidal neurons by postnatal exposure to MK-801: Effects of enriched environment. PG - 56-61 LID - S0736-5748(16)30257-X [pii] LID - 10.1016/j.ijdevneu.2017.01.006 [doi] AB - Early enriched environment (EE) prevents several deficits associated with postnatal MK-801 [N-Methyl-d-Aspartate (NMDA) receptor antagonist] treatment such as cognitive and locomotor deficits. We sought physiological correlates to such changes by looking at inhibitory synaptic inputs onto pyramidal cells in a prefrontal cortex slice preparation. Pharmacologically isolated gamma-amino-butyric acid (A) (GABA(A)) receptor-mediated currents were measured using whole-cell patch clamp recordings. Wistar rats were raised in standard or EE from birth up to the time of experiments and were injected with saline or MK-801 (1mg/kg) on postnatal days (P) 6-10. We recorded miniature inhibitory post-synaptic currents (mIPSCs) of pyramidal cells in layer II/III of prefrontal cortex and measured their frequency, amplitude and kinetics. In control animals, the amplitude and frequency of mIPSCs increased strikingly during development from P21 to P28. MK-801 accelerated the development of mIPSCs frequency but caused a significant decrease in the amplitude of mIPSCs on P28 suggesting a significant reduction of inhibition onto pyramidal cells. EE per se led to a significant increase in both frequency and amplitude of mIPSCs, but its application to MK-801-treated rats resulted in moderate rescue of GABAergic transmission on P28. We conclude that postnatal MK-801 leads to reduced inhibitory transmission onto pyramidal cells of prefrontal cortex at adolescence which may underlie behavioural and morphological differences detected in vivo in rats. EE presentation from birth rather prevents GABAergic alterations associated with postnatal MK-801 treatment at adolescence. CI - Copyright (c) 2017 ISDN. Published by Elsevier Ltd. All rights reserved. FAU - Shojaei, Amir AU - Shojaei A AD - Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. FAU - Anaraki, Afsaneh Kamali AU - Anaraki AK AD - Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. FAU - Mirnajafi-Zadeh, Javad AU - Mirnajafi-Zadeh J AD - Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. FAU - Atapour, Nafiseh AU - Atapour N AD - Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran; Neuroscience Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria 3800, Australia. Electronic address: nafiseh.atapour@monash.edu. LA - eng PT - Journal Article DEP - 20170115 PL - United States TA - Int J Dev Neurosci JT - International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience JID - 8401784 RN - 0 (Excitatory Amino Acid Antagonists) RN - 0 (GABA-A Receptor Antagonists) RN - 6LR8C1B66Q (Dizocilpine Maleate) RN - Y37615DVKC (Bicuculline) SB - IM MH - Age Factors MH - Animals MH - Animals, Newborn MH - Bicuculline/pharmacology MH - Dizocilpine Maleate/*pharmacology MH - Electric Stimulation MH - *Environment MH - Excitatory Amino Acid Antagonists/*pharmacology MH - Female MH - GABA-A Receptor Antagonists/pharmacology MH - In Vitro Techniques MH - Inhibitory Postsynaptic Potentials/*drug effects MH - Male MH - Patch-Clamp Techniques MH - Prefrontal Cortex/*cytology MH - Pregnancy MH - Pyramidal Cells/*drug effects MH - Rats MH - Rats, Wistar OTO - NOTNLM OT - Development OT - Enriched environment OT - Inhibitory synaptic currents OT - NMDA receptor antagonist OT - Prefrontal cortex OT - Schizophrenia EDAT- 2017/01/19 06:00 MHDA- 2017/03/31 06:00 CRDT- 2017/01/19 06:00 PHST- 2016/09/20 00:00 [received] PHST- 2017/01/12 00:00 [revised] PHST- 2017/01/12 00:00 [accepted] PHST- 2017/01/19 06:00 [pubmed] PHST- 2017/03/31 06:00 [medline] PHST- 2017/01/19 06:00 [entrez] AID - S0736-5748(16)30257-X [pii] AID - 10.1016/j.ijdevneu.2017.01.006 [doi] PST - ppublish SO - Int J Dev Neurosci. 2017 Apr;57:56-61. doi: 10.1016/j.ijdevneu.2017.01.006. Epub 2017 Jan 15.